George Elston

Insider Reports History

Entity
Individual
Location
124 Chatham Street, Chatham, NJ
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Elston:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Chief Financial Officer Common Stock 68.6K $595K $8.68 Jan 6, 2025 Direct
EyePoint Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 14.7K $128K $8.68 Jan 6, 2025 Direct
EyePoint Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 117K Jan 3, 2025 Direct

Insider Reports Filed by George Elston

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EYPT EyePoint Pharmaceuticals, Inc. Jan 3, 2025 8 -$85.2K 4 Jan 7, 2025 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. May 25, 2024 3 -$40.5K 4 May 28, 2024 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2024 6 -$91.9K 4 Feb 13, 2024 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 5 -$100K 4 Jan 9, 2024 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Oct 16, 2023 1 $0 4 Oct 17, 2023 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 1 $0 4 Jun 22, 2023 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. May 25, 2023 2 $0 4 May 30, 2023 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2023 4 $0 4 Feb 13, 2023 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Jan 6, 2023 1 $0 4 Jan 10, 2023 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2022 5 -$17.4K 4 Feb 11, 2022 Chief Financial Officer
EYPT EyePoint Pharmaceuticals, Inc. Jun 22, 2021 2 $0 4 Jun 23, 2021 Chief Financial Officer